Profile data is unavailable for this security.
About the company
Hologic, Inc. is a medical technology company focused on improving women's health and well-being through early detection and treatment. It is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. It also offers wireless breast surgery localization and lymphatic tracing solutions. GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
- Revenue in USD (TTM)3.99bn
- Net income in USD701.50m
- Incorporated1990
- Employees6.99k
- LocationHologic Inc250 Campus DriveMARLBOROUGH 1752United StatesUSA
- Phone+1 (508) 263-2900
- Fax+1 (302) 655-5049
- Websitehttps://www.hologic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teleflex Inc | 3.01bn | 264.76m | 11.38bn | 14.50k | 43.17 | 2.50 | 21.85 | 3.78 | 5.59 | 5.57 | 63.54 | 96.76 | 0.4196 | 2.09 | 6.85 | 207,437.10 | 3.69 | 5.86 | 4.00 | 6.42 | 55.86 | 54.43 | 8.80 | 14.62 | 1.44 | 7.14 | 0.2737 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Revvity Inc | 2.71bn | 197.34m | 15.37bn | 11.50k | 78.01 | 1.95 | 24.53 | 5.67 | 1.60 | 1.37 | 21.90 | 63.80 | 0.1959 | 2.89 | 4.42 | 235,499.60 | 1.43 | 4.76 | 1.59 | 5.39 | 55.26 | 57.19 | 7.29 | 15.34 | 1.98 | 6.89 | 0.3299 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Insulet Corp | 1.87bn | 395.30m | 16.55bn | 3.00k | 43.62 | 16.58 | 35.16 | 8.84 | 5.41 | 5.41 | 24.53 | 14.24 | 0.711 | 1.38 | 6.25 | 624,233.30 | 15.01 | 2.71 | 18.15 | 3.14 | 69.00 | 65.81 | 21.11 | 4.28 | 2.71 | 87.97 | 0.5833 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Avantor Inc | 6.83bn | 360.20m | 18.40bn | 14.50k | 51.10 | 3.38 | 24.17 | 2.70 | 0.5295 | 0.5295 | 10.03 | 8.00 | 0.530 | 5.37 | 5.82 | 470,731.00 | 2.80 | 2.97 | 3.17 | 3.35 | 33.71 | 33.44 | 5.28 | 5.06 | 1.05 | 3.07 | 0.4848 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
| Align Technology, Inc. | 3.94bn | 447.03m | 18.90bn | 21.61k | 42.91 | 5.03 | 32.20 | 4.79 | 5.90 | 5.90 | 52.03 | 50.31 | 0.641 | 4.16 | 4.09 | 182,455.40 | 7.27 | 16.34 | 10.96 | 24.14 | 69.82 | 71.72 | 11.34 | 23.16 | 1.06 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Hologic Inc | 3.99bn | 701.50m | 18.98bn | 6.99k | 27.89 | 3.83 | 18.77 | 4.76 | 2.93 | 2.93 | 16.59 | 21.33 | 0.4375 | 2.64 | 6.06 | 570,472.10 | 7.70 | 11.40 | 8.64 | 13.38 | 55.41 | 60.29 | 17.59 | 20.95 | 3.32 | 709.77 | 0.3408 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Waters Corp | 2.88bn | 595.69m | 19.79bn | 7.90k | 33.21 | 14.01 | 25.13 | 6.88 | 10.04 | 10.04 | 48.46 | 23.79 | 0.6394 | 2.19 | 4.41 | 364,118.20 | 13.24 | 19.77 | 16.04 | 25.29 | 59.68 | 58.45 | 20.71 | 23.38 | 1.42 | 8.74 | 0.5869 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| Baxter International Inc | 15.00bn | -157.00m | 20.09bn | 60.00k | -- | 2.63 | 18.10 | 1.34 | -0.3066 | 4.87 | 29.48 | 14.98 | 0.5534 | 3.24 | 5.73 | 249,950.00 | -0.5462 | 0.1942 | -0.7019 | 0.2333 | 36.48 | 38.20 | -0.9869 | 0.3674 | 0.9147 | 4.25 | 0.626 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Illumina Inc | 4.43bn | -3.04bn | 20.86bn | 10.59k | -- | 14.50 | -- | 4.71 | -19.18 | -19.18 | 27.94 | 9.03 | 0.4961 | 2.86 | 6.26 | 418,224.80 | -34.09 | -6.20 | -45.61 | -7.28 | 62.00 | 66.39 | -68.71 | -15.48 | 0.8596 | 14.07 | 0.6087 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| Zimmer Biomet Holdings Inc | 7.52bn | 997.10m | 21.64bn | 18.00k | 22.15 | 1.71 | 11.03 | 2.88 | 4.80 | 4.80 | 36.22 | 62.18 | 0.3515 | 0.9141 | 5.40 | 418,050.00 | 4.66 | 2.21 | 5.40 | 2.52 | 71.78 | 71.25 | 13.27 | 7.28 | 0.629 | 7.51 | 0.314 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Cooper Companies Inc | 3.80bn | 359.30m | 22.01bn | 15.00k | 61.55 | 2.78 | 29.90 | 5.79 | 1.80 | 1.80 | 19.02 | 39.80 | 0.3196 | 1.70 | 5.56 | 253,606.70 | 3.02 | 10.06 | 3.29 | 11.34 | 66.36 | 65.54 | 9.45 | 29.00 | 1.18 | 5.46 | 0.2493 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| West Pharmaceutical Services Inc. | 2.88bn | 524.90m | 22.43bn | 10.60k | 43.93 | 8.71 | 34.23 | 7.80 | 7.04 | 7.04 | 38.62 | 35.49 | 0.8037 | 4.26 | 5.68 | 271,405.70 | 14.22 | 15.61 | 16.93 | 18.65 | 35.69 | 38.06 | 17.70 | 18.47 | 1.68 | -- | 0.0751 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Steris PLC | 5.13bn | 567.70m | 23.51bn | 18.18k | 41.66 | 3.71 | 21.19 | 4.58 | 5.72 | 4.03 | 51.73 | 64.32 | 0.4914 | 3.98 | 5.77 | 282,395.10 | 5.45 | 5.19 | 5.95 | 5.68 | 43.19 | 43.64 | 11.09 | 10.97 | 1.49 | 7.03 | 0.2666 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
| DexCom Inc | 3.93bn | 666.90m | 27.83bn | 9.60k | 43.61 | 11.43 | 31.91 | 7.07 | 1.59 | 1.59 | 9.38 | 6.08 | 0.5778 | 2.92 | 4.64 | 409,875.00 | 9.79 | 8.30 | 13.57 | 10.50 | 63.16 | 65.90 | 16.95 | 14.14 | 2.48 | -- | 0.5063 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
Data as of Sep 19 2024. Currency figures normalised to Hologic Inc's reporting currency: US Dollar USD
43.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 25.75m | 11.09% |
| T. Rowe Price Investment Management, Inc.as of 30 Jun 2024 | 22.46m | 9.67% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 13.92m | 5.99% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 10.33m | 4.45% |
| Morgan Stanley Investment Management Ltd.as of 30 Jun 2024 | 5.86m | 2.52% |
| Victory Capital Management, Inc. (Investment Management)as of 30 Jun 2024 | 5.66m | 2.44% |
| Geode Capital Management LLCas of 30 Jun 2024 | 5.57m | 2.40% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2024 | 5.54m | 2.39% |
| Macquarie Investment Management Business Trustas of 30 Jun 2024 | 3.67m | 1.58% |
| Columbia Management Investment Advisers LLCas of 30 Jun 2024 | 3.38m | 1.46% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
